欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号ES/H/0575/009
药品名称STRATTERA 4 MG/ML SOLUCION ORAL
活性成分
    • ATOMOXETINE HYDROCHLORIDE 4.0 mg/ml
剂型Oral solution
上市许可持有人Eli Lilly and Company Limited, Lilly House, Priestley Road, Basingstoke, Hampshire RG24 9NL United Kingdom
参考成员国 - 产品名称Spain (ES)
互认成员国 - 产品名称
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Germany (DE)
      Stratera 4 mg/ml lösung zum Einnehmen
    • Denmark (DK)
    • Ireland (IE)
    • Austria (AT)
      Strattera 4 mg/ml Lösung zum Einnehmen
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
      50612
    • Norway (NO)
      Strattera
    • Hungary (HU)
      STRATTERA 4 mg/ml belsőleges oldat
    • Romania (RO)
      Strattera 4 mg/ml soluţie orală
    • Malta (MT)
      Strattera 4mg/ml oral solution
许可日期2014/10/04
最近更新日期2024/01/02
药物ATC编码
    • N06BA09 atomoxetine
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase